Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.
Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of pharmaceutical products and molecular medicine. Related news and announcements can also published. Our aim is to publish as much as possible the theoretical and experimental details. Therefore, there is no restriction on the length of a paper. There are in addition three unique features: Manuscripts regarding research proposals and research ideas will be particularly welcomed. Electronic files regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, will be deposited as supplementary material. Samples of the pharmaceutical products can be deposited into the samples collection of MDPI.
Pharmacogenetics and Genomics is a unique and innovative journal that covers genetic variation in response to drugs and other chemicals in humans and animals. Its impressive impact factor rating of 4.409 (Pharmacology and Pharmacy, Genetics and Heredity, and Biotechnology & Applied Microbiology, 2008 SCI169; Report) is testament to its quality and standing in this field.Pharmacogenetics and Genomics unites contributions of importance to clinical pharmacologists, biochemists, geneticists, epidemiologists and molecular biologists. The journal publishes studies that identify and characterize polymorphic genes encoding drug metabolizing enzymes, drug receptors and drug transporters. Coverage also includes papers on the effects of gene expression on the disposition and metabolism of foreign chemicals.Full text online at www.pharmacogeneticsandgenomics.com.
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Pharmacogenomics aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.
The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.
This quarterly journal showcases important review articles on topics of high current interest. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.
Phytochemical Analysisis devoted to the publication of original articles concerning the development, improvement, validation and/or extension of application of analytical methodology in the plant sciences. The spectrum of coverage is broad, encompassing methods and techniques relevant to the detection (including bio-screening), extraction, separation, purification, identification and quantification of compounds in plant biochemistry, plant cellular and molecular biology, plant biotechnology, the food sciences, agriculture and horticulture. The Journal publishes papers describing significant novelty in the analysis of whole plants (including algae), plant cells, tissues and organs, plant-derived extracts and plant products (including those which have been partially or completely refined for use in the food, agrochemical, pharmaceutical and related industries). All forms of physical, chemical, biochemical, spectroscopic, radiometric, electrometric, chromatographic, metabolomic and chemometric investigations of plant products (monomeric species as well as polymeric molecules such as nucleic acids, proteins, lipids and carbohydrates) are included within the remit of the Journal. Papers dealing with novel methods relating to areas such as data handling/ data mining in plant sciences will also be welcomed. Phytochemical Analysisis intended to serve as a major resource for information on analytical and instrumental methodology in the plant sciences. Together with original articles and accelerated communications, all of which will be both timely and of interest to a wide readership, short review articles describing recent advances in specific areas of plant analysis will be published. Reviews are by invitation only, but the Editor-in-Chief welcomes suggestions for new review topics from potential authors.
Phytomedicine is published to attract and disseminate innovative and expert findings in the fields of phytopharmacology, phytotherapy and phytotoxicology, as a reference source for researchers in these fields, and with the aim to set international standards in their methodology. The journal publishes research results on phytotherapy (clinical trials), phytopharmacology, pharmacognosy, standardization and phytotoxicology, obtained with plant extracts as well as isolated compounds from these extracts and phytopharmaceuticals. Phytomedicine is targeted towards papers of a practical nature. The papers published in this journal are also useful to drug regulatory authorities in deciding whether to approve certain phytomedicines or not. Phytomedicine consists of the following sections: Case reports, Pharmacological and molecularbiological studies, Screening studies (only when focused on plant extracts or isolated compounds with extraordinary activities, Chemical structure - activity studies, Chemical analysis and standardization of plant drugs and phytopharmaceuticals, Reviews (by invitation).
Planta Medica is one of the leading international journals in the field of medicinal plants and natural products with original research papers, letters, rapid communications, reviews, minireviews and perspectives from researchers worldwide. From 2011 Planta Medica will publish 18 issues per year.The following areas of medicinal plants and natural products are covered:* Biological and Pharmacological Activity* Pharmacokinetic and Clinical Studies* Natural Product Chemistry* Analytical Studies.
Probiotics and Antimicrobial Proteins publishes reviews, original articles, letters (short notes) and technical (methodological) communications targeted towards the advancement of the fundamental knowledge and exploration of the applications of probiotics, natural antimicrobial proteins and their derivatives in biomedical, agricultural, veterinary, food, and cosmetic products. The Journal equally welcomes fundamental research articles and reports on applications of these microorganisms and substances. The Journal encourages structural studies and studies that correlate the structure and functional properties of antimicrobial proteins. Authors are expected to submit manuscripts dealing with all aspects of probiotics and antimicrobial peptides, from their discovery and understanding mechanisms of action to biophysical experiments/simulations that clarify mechanisms of action on molecular level, testing pharmacological profiles (activity and toxicity) and design of novel antimicrobial proteins and/or probiotic-containing or probiotic-derived products with therapeutic, food or consumer health formulation potential.
RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.
RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.
SAR and QSAR in Environmental Research is an international journal welcoming papers on the fundamental and practical aspects of the structure-activity and structure-property relationships in the fields of environmental science, agrochemistry, toxicology, pharmacology and applied chemistry. A unique aspect of the journal is the focus on emerging techniques for the building of SAR and QSAR models in these widely varying fields. The scope of the journal includes, but is not limited to, the topics of topological and physicochemical descriptors, mathematical, statistical and graphical methods for data analysis, computer methods and programs, original applications and comparative studies. In addition to primary scientific papers, the journal contains reviews of books and software and news of conferences. Special issues on topics of current and widespread interest to the SAR and QSAR community will be published from time to time.Discounted society rate available for the QSAR and Modelling Society members.All published research articles in SAR and QSAR in Environmental Research have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two independent expert referees.DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.
Stem Cell Research & Therapy is the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it publishes high quality open access research articles with a special emphasis on basic, translational and clinical research into stem cell therapeutics and regenerative therapies, including animal models and clinical trials. The journal also provides reviews, viewpoints, commentaries and reports.
STEM CELLS, a peer-reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.
STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cell research including embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.